Iris Cohn

529 total citations
19 papers, 144 citations indexed

About

Iris Cohn is a scholar working on Pediatrics, Perinatology and Child Health, Genetics and Pharmacology. According to data from OpenAlex, Iris Cohn has authored 19 papers receiving a total of 144 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pediatrics, Perinatology and Child Health, 9 papers in Genetics and 6 papers in Pharmacology. Recurrent topics in Iris Cohn's work include Pharmaceutical studies and practices (10 papers), Genomics and Rare Diseases (8 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Iris Cohn is often cited by papers focused on Pharmaceutical studies and practices (10 papers), Genomics and Rare Diseases (8 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Iris Cohn collaborates with scholars based in Canada, United States and Israel. Iris Cohn's co-authors include Shinya Ito, Ronald D. Cohn, Robin Z. Hayeems, M. Stephen Meyn, Stephen W. Scherer, Christian R. Marshall, Dimitri J. Stavropoulos, Nasim Monfared, Raveen Basran and Raymond H. Kim and has published in prestigious journals such as Pediatric Research, Human Genetics and JAMA Network Open.

In The Last Decade

Iris Cohn

13 papers receiving 140 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Iris Cohn Canada	7	78	69	54	20	19	19	144
Suzanne Herd United States	2	161 2.1×	74 1.1×	37 0.7×	26 1.3×	58 3.1×	2	226
Catherine Hajek United States	7	67 0.9×	51 0.7×	34 0.6×	5 0.3×	28 1.5×	22	160
T. Sirisinha Thailand	5	42 0.5×	50 0.7×	21 0.4×	4 0.2×	18 0.9×	9	176
A. Keith Stewart United States	4	35 0.4×	55 0.8×	32 0.6×	9 0.5×	125 6.6×	14	213
Amy L. Pasternak United States	10	24 0.3×	96 1.4×	73 1.4×	4 0.2×	41 2.2×	27	212
Chia Wei Lim Singapore	5	20 0.3×	38 0.6×	17 0.3×	5 0.3×	37 1.9×	8	118
Ragan Hart United States	6	89 1.1×	15 0.2×	29 0.5×	8 0.4×	12 0.6×	7	138
Jennifer M. Skierka United States	6	30 0.4×	130 1.9×	133 2.5×	3 0.1×	63 3.3×	8	247
Adam M Lee United States	7	17 0.2×	22 0.3×	19 0.4×	8 0.4×	65 3.4×	10	165
Irene Dapía Spain	7	36 0.5×	45 0.7×	27 0.5×	4 0.2×	48 2.5×	9	126

Countries citing papers authored by Iris Cohn

Since Specialization

Citations

This map shows the geographic impact of Iris Cohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Cohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Cohn more than expected).

Fields of papers citing papers by Iris Cohn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris Cohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Cohn. The network helps show where Iris Cohn may publish in the future.

Co-authorship network of co-authors of Iris Cohn

This figure shows the co-authorship network connecting the top 25 collaborators of Iris Cohn. A scholar is included among the top collaborators of Iris Cohn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iris Cohn. Iris Cohn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Marcon, Margaret, Ruud H J Verstegen, Shinya Ito, et al.. (2025). Optimizing proton-pump inhibitor therapy in paediatric eosinophilic esophagitis through CYP2C19 pharmacogenetic testing. Journal of the Canadian Association of Gastroenterology. 8(3). 89–96.

Manshaei, Roozbeh, et al.. (2024). A call for increased inclusivity and global representation in pharmacogenetic testing. npj Genomic Medicine. 9(1). 13–13. 3 indexed citations

Verstegen, Ruud H J, Iris Cohn, Mark Feldman, Daniel Gorman, & Shinya Ito. (2024). Gene-based drug therapy for children and youth treated with psychoactive medications. Paediatrics & Child Health. 29(5). 318–323.

Verstegen, Ruud H J, Iris Cohn, Mark Feldman, Daniel Gorman, & Shinya Ito. (2024). La pharmacothérapie en fonction des gènes chez les enfants et les adolescents qui prennent des médicaments psychoactifs. Paediatrics & Child Health. 29(5). 311–317.

Cohn, Ronald D., et al.. (2023). Urgent call for guidance supporting gene-based drug dosing in children and adolescents. Paediatrics & Child Health. 28(4). 205–207. 1 indexed citations

Khan, Tayyaba, Meredith Curtis, Eyal Cohen, et al.. (2022). Pharmacogenetic profiling via genome sequencing in children with medical complexity. Pediatric Research. 93(4). 905–910. 6 indexed citations

Tsiplova, Kate, Robin Z. Hayeems, Christian R. Marshall, et al.. (2022). Trio genome sequencing for developmental delay and pediatric heart conditions: A comparative microcost analysis. Genetics in Medicine. 24(5). 1027–1036. 9 indexed citations

Cohn, Iris, et al.. (2022). A129 CYP2C19 PHARMACOGENETIC TESTING IN PAEDIATRIC PATIENTS WITH EOSINOPHILIC ESOPHAGITIS INFLUENCES DOSING OF PROTON-PUMP-INHIBITORS AND RESPONSE TO THERAPY. Journal of the Canadian Association of Gastroenterology. 5(Supplement_1). 152–153. 1 indexed citations

Liston, Eriskay, Rajiv Chaturvedi, Iris Cohn, et al.. (2022). A Model for the Integration of Genome Sequencing Into a Pediatric Cardiology Clinic. Canadian Journal of Cardiology. 38(9). 1454–1457.

10.

Cohn, Iris, Roozbeh Manshaei, Eriskay Liston, et al.. (2021). Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care Setting. JAMA Network Open. 4(5). e2110446–e2110446. 24 indexed citations

11.

Godoy, Lucas C., George Tomlinson, Michael E. Farkouh, et al.. (2021). Association between time to therapeutic INR and length of stay following mechanical heart valve surgery. Journal of Cardiac Surgery. 37(1). 62–69. 2 indexed citations

12.

Reble, Emma, Sam Khalouei, Marc Clausen, et al.. (2020). Beyond medically actionable results: an analytical pipeline for decreasing the burden of returning all clinically significant secondary findings. Human Genetics. 140(3). 493–504. 11 indexed citations

13.

Mulder, Daniel J., Sam Khalouei, Neil Warner, et al.. (2020). Utilization of Whole Exome Sequencing Data to Identify Clinically Relevant Pharmacogenomic Variants in Pediatric Inflammatory Bowel Disease. Clinical and Translational Gastroenterology. 11(12). e00263–e00263. 1 indexed citations

14.

Shuman, Cheryl, et al.. (2019). Perplexed by PGX? Exploring the Impact of Pharmacogenomic Results on Medical Management, Disclosures and Patient Behavior. Pharmacogenomics. 20(5). 319–329. 9 indexed citations

15.

Cohn, Iris, Ronald D. Cohn, & Shinya Ito. (2018). Professional opportunity for pharmacists to integrate pharmacogenomics in medication therapy. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 151(3). 167–169. 11 indexed citations

16.

Cohn, Iris, Tara Paton, Christian R. Marshall, et al.. (2017). Genome sequencing as a platform for pharmacogenetic genotyping: a pediatric cohort study. npj Genomic Medicine. 2(1). 19–19. 38 indexed citations

17.

Hayeems, Robin Z., Jasmin Bhawra, Kate Tsiplova, et al.. (2017). Care and cost consequences of pediatric whole genome sequencing compared to chromosome microarray. European Journal of Human Genetics. 25(12). 1303–1312. 27 indexed citations

18.

Cohn, Iris. (1973). Presidential address: "Surgical education and the community hospital".. PubMed. 39(10). 537–42.

19.

Cohn, Iris. (1954). Untoward reactions from phenylbutazone.. PubMed. 54(9). 1369–70. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact